BioTel Care, a BioTelemetry Company, Announces Release of Next-Generation Wireless Blood Glucose Monitor
June 13 2018 - 8:05AM
(NASDAQ:BEAT) – BioTel CareTM (formally known as Telcare), a
BioTelemetry company, announced today the release of its
next-generation wireless blood glucose monitor for diabetes
management.
As an industry pioneer, BioTel Care developed the
first FDA-cleared, cellular-enabled glucometer which supports
real-time transmission and consolidation of patient data in an
FDA-cleared cloud. Building on the success of this
technology, BioTel Care is launching its next-generation blood
glucose monitor, which includes an innovative touch-screen user
interface, enabling patients to easily test blood glucose levels
while capturing additional personal health data. The
monitor’s remote capabilities allow patients to quickly communicate
a wide range of relevant health information to their care
providers. Clinicians can access and track their patients’
data through the BioTel Care cloud and can provide immediate
feedback, as needed, directly to their patients via the new
monitor’s messaging feature. Patients can also track their
own data with informative graphical summaries available on the
monitor. Both clinicians and patients will benefit from the
system’s ability to be paired with other connected health devices,
providing the option to consolidate various types of health
information into a single, cloud-based repository.
Joseph H. Capper, President and Chief Executive Officer of
BioTelemetry, Inc., noted: “This next generation blood glucose
monitor is a great addition to our product portfolio and continues
our commitment to innovate connected health solutions suited for
today’s rapidly evolving healthcare market. The design
emphasizes usability, encouraging greater compliance and improved
patient engagement. The BioTel Care monitor also features the
ability to consolidate data from other connected health devices,
uniquely positioning us to move beyond diabetes and into the
management of other chronic conditions.”
About BioTelemetry BioTelemetry, Inc. is
the leading wireless medical technology company focused on the
delivery of health information to improve quality of life and
reduce cost of care. The BioTel Care division, formerly known
as Telcare, was acquired by BioTelemetry in December 2016.
Telcare, a leading digital-health company, pioneered
development of the first FDA-cleared, cellular-enabled
glucometer and cloud-based diabetes data repository. The
Company’s focus is on providing a comprehensive suite of offerings
to support diabetes management, combining a connected glucometer,
cloud-based analytics and care management tools that enhance care
for people living with diabetes. More information can be
found at www.gobio.com.
Contact:BioTelemetry, Inc.Heather C. GetzInvestor
Relations800-908-7103investorrelations@biotelinc.com
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Mar 2024 to Apr 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Apr 2023 to Apr 2024